BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070113. A total of 6 filers reported holding BONE BIOLOGICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,973 | +62.4% | 38,690 | -5.9% | 0.00% | – |
| Q4 2022 | $1,215 | -90.7% | 41,100 | -58.7% | 0.00% | -100.0% |
| Q3 2022 | $13,000 | -38.1% | 99,435 | -9.2% | 0.00% | -60.0% |
| Q2 2022 | $21,000 | -72.4% | 109,567 | -50.0% | 0.01% | – |
| Q1 2022 | $76,000 | +181.5% | 219,134 | +461.8% | 0.00% | -100.0% |
| Q4 2021 | $27,000 | – | 39,003 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 140,471 | $48,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 108,476 | $37,000 | 0.01% |
| CLEAR STREET LLC | 20,000 | $7,000 | 0.00% |
| Warberg Asset Management LLC | 219,134 | $76,000 | 0.00% |
| UBS Group AG | 10,893 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |